性器ヘルペスの世界市場レポート 2025年

性器ヘルペス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で30億5,000万米ドルに成長します。予測期間の成長は、認知度と教育の向上、治療とワクチンの進歩、罹患率の増加、デジタルヘルス技術、ヘルスケアアクセスの拡大、STI啓発プログラムの高まりに起因すると考えられます。予測期間の主な動向には、遠隔医療の採用、抗ウイルス療法の進歩、ワクチンの研究開発、医療アクセスの拡大、啓発キャンペーンの強化、AIとデータ分析の統合などがあります。

性器ヘルペス市場は、セクシュアル・ヘルスへの関心の高まりに牽引され、成長の態勢を整えています。この注目は、全体的な幸福と生活の質における極めて重要な役割に対する理解の高まりを反映しています。性器ヘルペスの性的健康サービスは、診断、治療、カウンセリング、継続的な管理を包括しています。これらのサービスは、性感染症の発生を管理し、トランスミッションを予防し、性感染症に関連する感情的・人間関係的課題に対処する上で個人を支援するものです。特に、地方自治体協会は、2022年の性的健康相談件数が33％急増し、合計450万件となり、診断検査件数も2021年と比較して13％増加し、合計220万件となったと報告しています。このように、性の健康への関心の高まりが性器ヘルペス市場を押し上げると予想されます。

性器ヘルペス市場の主要企業は、技術力と市場での存在感を高めるために戦略的パートナーシップを結んでいます。このようなパートナーシップは、共通の目的に向かってリソースや専門知識を結集するための組織間の協力的な取り組みです。例えば、2022年6月、Eurocine Vaccines ABはRedbiotec AGと調査協力契約を締結しました。この提携により、単純ヘルペスウイルス2型（HSV-2）を標的とするワクチン候補の開発、製造、商品化に関する独占的な世界権利が、mRNAおよびタンパク質ベースの技術を利用してEurocine Vaccines社に付与されました。Eurocine Vaccines社は、その後の第三者とのライセンシング契約が成立するまでの間、開発・製造・商業化に関するすべての活動を管理し、資金を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界性器ヘルペス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の性器ヘルペス市場：成長率分析
• 世界の性器ヘルペス市場の実績：規模と成長, 2019-2024
• 世界の性器ヘルペス市場の予測：規模と成長, 2024-2029, 2034F
• 世界性器ヘルペス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の性器ヘルペス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 治療
• 世界の性器ヘルペス市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射剤
• トピック
• 世界の性器ヘルペス市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• その他の流通チャネル
• 世界の性器ヘルペス市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）検査
• ウイルス培養検査
• 血液抗体検査（血清学）
• 抗原検出検査
• ポイントオブケア迅速検査
• 世界の性器ヘルペス市場、治療の細分化、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ウイルス薬
• アシクロビル
• バラシクロビル
• ファムシクロビル
• 局所治療
• アシクロビルクリーム
• ドコサノールクリーム
• 予防療法
• 抑制療法
• 予防ワクチン（開発中）
• 疼痛管理薬
• 鎮痛剤
• 局所麻酔薬

第7章 地域別・国別分析

• 世界の性器ヘルペス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の性器ヘルペス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 性器ヘルペス市場：競合情勢
• 性器ヘルペス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• BioNTech SE
• Viatris Inc.
• Teva Pharmaceuticals Inc.
• Sandoz Inc.
• Fresenius Kabi AG
• Valeant Pharmaceuticals International Inc.
• Sun Pharmaceutical Industries Ltd.
• Bausch+Lomb Corporation
• Dr. Reddy's Laboratories Ltd.
• Apotex Inc.
• Zydus Group
• Genocea Biosciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 性器ヘルペス市場2029：新たな機会を提供する国
• 性器ヘルペス市場2029：新たな機会を提供するセグメント
• 性器ヘルペス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genital herpes is a sexually transmitted infection (STI) caused primarily by the herpes simplex virus type 2 (HSV-2) or, less commonly, by the herpes simplex virus type 1 (HSV-1). It typically appears as sores or blisters on the genital area, buttocks, or anal region. Transmission occurs through sexual contact with an infected person. Antiviral medications are used to manage symptoms and reduce the risk of transmission to sexual partners.

The diagnosis and treatment of genital herpes involve identifying the infection in patients through methods such as physical examinations, laboratory tests, and reviewing patient history. Treatment methods include oral, injectable, and topical medications, distributed through hospital pharmacies, retail pharmacies, and other channels.

The genital herpes market research report is one of a series of new reports from the business research company that provides genital herpes market statistics, including genital herpes industry global market size, regional shares, competitors with an genital herpes market share, detailed genital herpes market segments, market trends and opportunities, and any further data you may need to thrive in the genital herpes industry. This genital herpes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genital herpes market size has grown strongly in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing awareness and diagnosis, increasing advancements in treatment, improved access to healthcare, public health campaigns, and socio-demographic factors.

The genital herpes market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to growing awareness and education, advancements in treatment and vaccines, increasing incidence rates, digital health technologies, expanding healthcare access, and rising STI awareness programs. Major trends in the forecast period include the adoption of telemedicine, advancements in antiviral therapies, research and development in vaccines, expansion of healthcare access, enhanced public awareness campaigns, and the integration of AI and data analytics.

The genital herpes market is poised for growth, driven by increasing attention to sexual health. This focus reflects a growing understanding of its pivotal role in overall well-being and life quality. Sexual health services for genital herpes encompass diagnosis, treatment, counseling, and ongoing management. These services support individuals in managing outbreaks, preventing transmission, and addressing emotional and relationship challenges linked to the condition. Notably, the Local Government Association reported a 33% surge in sexual health consultations in 2022, totaling 4.5 million, along with a 13% increase in diagnostic tests, totaling 2.2 million compared to 2021. Thus, the heightened emphasis on sexual health is expected to boost the genital herpes market.

Major companies in the genital herpes market, are embracing strategic partnerships to bolster their technological capabilities and market presence. These partnerships involve collaborative efforts between organizations to combine resources and expertise toward shared objectives. For instance, in June 2022, Eurocine Vaccines AB entered into a research and collaboration agreement with Redbiotec AG. This partnership grants Eurocine Vaccines exclusive global rights for developing, manufacturing, and commercializing vaccine candidates targeting Herpes Simplex Virus Type 2 (HSV-2), utilizing mRNA- and protein-based technologies. Eurocine Vaccines will manage and finance all activities related to development, manufacturing, and commercialization until a subsequent out-licensing agreement with a third party is secured.

In July 2022, Flerie Invest AB, a Sweden-based investment company specializing in the pharmaceuticals and healthcare sectors, acquired a 15% stake in Eurocine Vaccines AB for an undisclosed sum. This investment is aimed at accelerating the development of medical innovations that address critical patient needs. Flerie Invest intends to support the advancement of Eurocine Vaccines' pipeline of products under development, consistent with its strategy of investing in the biotechnology and life sciences industries. Eurocine Vaccines AB, headquartered in Sweden, focuses on developing therapies and products for the treatment of genital herpes disease.

Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE, Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr Reddy's Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB, Vical Incorporated

North America was the largest region in the genital herpes market in 2024. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genital herpes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genital herpes market consists of revenues earned by entities by providing services such as diagnostic testing, patient education, counseling, and management of symptoms and outbreaks. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital herpes market also includes sales of antiviral medications, topical treatments, diagnostic test kits, and preventive products such as vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genital Herpes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genital herpes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genital herpes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genital herpes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Treatment
• 2) By Route Of Administration: Oral; Injectable; Topical
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channel
• Subsegments:
• 1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests; Viral Culture Tests; Blood Antibody Tests (Serology); Antigen Detection Tests; Point-Of-Care Rapid Tests
• 2) By Treatment: Antiviral Medications; Acyclovir; Valacyclovir; Famciclovir; Topical Treatments; Acyclovir Cream; Docosanol Cream; Preventive Therapies; Suppressive Therapy; Prophylactic Vaccines (Under Development); Pain Management Medications; Analgesics; Topical Anesthetics
• Companies Mentioned: Pfizer Inc; Roche Holding AG; Merck & Co. Inc. ; AbbVie Inc.; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genital Herpes Market Characteristics

3. Genital Herpes Market Trends And Strategies

4. Genital Herpes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genital Herpes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genital Herpes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genital Herpes Market Growth Rate Analysis
• 5.4. Global Genital Herpes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genital Herpes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genital Herpes Total Addressable Market (TAM)

6. Genital Herpes Market Segmentation

• 6.1. Global Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• 6.2. Global Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• 6.3. Global Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Other Distribution Channel
• 6.4. Global Genital Herpes Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Tests
• Viral Culture Tests
• Blood Antibody Tests (Serology)
• Antigen Detection Tests
• Point-Of-Care Rapid Tests
• 6.5. Global Genital Herpes Market, Sub-Segmentation Of Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiviral Medications
• Acyclovir
• Valacyclovir
• Famciclovir
• Topical Treatments
• Acyclovir Cream
• Docosanol Cream
• Preventive Therapies
• Suppressive Therapy
• Prophylactic Vaccines (Under Development)
• Pain Management Medications
• Analgesics
• Topical Anesthetics

7. Genital Herpes Market Regional And Country Analysis

• 7.1. Global Genital Herpes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genital Herpes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genital Herpes Market

• 8.1. Asia-Pacific Genital Herpes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genital Herpes Market

• 9.1. China Genital Herpes Market Overview
• 9.2. China Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genital Herpes Market

• 10.1. India Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genital Herpes Market

• 11.1. Japan Genital Herpes Market Overview
• 11.2. Japan Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genital Herpes Market

• 12.1. Australia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genital Herpes Market

• 13.1. Indonesia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genital Herpes Market

• 14.1. South Korea Genital Herpes Market Overview
• 14.2. South Korea Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genital Herpes Market

• 15.1. Western Europe Genital Herpes Market Overview
• 15.2. Western Europe Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genital Herpes Market

• 16.1. UK Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genital Herpes Market

• 17.1. Germany Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genital Herpes Market

• 18.1. France Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genital Herpes Market

• 19.1. Italy Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genital Herpes Market

• 20.1. Spain Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genital Herpes Market

• 21.1. Eastern Europe Genital Herpes Market Overview
• 21.2. Eastern Europe Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genital Herpes Market

• 22.1. Russia Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genital Herpes Market

• 23.1. North America Genital Herpes Market Overview
• 23.2. North America Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genital Herpes Market

• 24.1. USA Genital Herpes Market Overview
• 24.2. USA Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genital Herpes Market

• 25.1. Canada Genital Herpes Market Overview
• 25.2. Canada Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genital Herpes Market

• 26.1. South America Genital Herpes Market Overview
• 26.2. South America Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genital Herpes Market

• 27.1. Brazil Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genital Herpes Market

• 28.1. Middle East Genital Herpes Market Overview
• 28.2. Middle East Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genital Herpes Market

• 29.1. Africa Genital Herpes Market Overview
• 29.2. Africa Genital Herpes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genital Herpes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genital Herpes Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genital Herpes Market Competitive Landscape And Company Profiles

• 30.1. Genital Herpes Market Competitive Landscape
• 30.2. Genital Herpes Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Genital Herpes Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. BioNTech SE
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceuticals Inc.
• 31.7. Sandoz Inc.
• 31.8. Fresenius Kabi AG
• 31.9. Valeant Pharmaceuticals International Inc.
• 31.10. Sun Pharmaceutical Industries Ltd.
• 31.11. Bausch + Lomb Corporation
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Apotex Inc.
• 31.14. Zydus Group
• 31.15. Genocea Biosciences Inc.

32. Global Genital Herpes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genital Herpes Market

34. Recent Developments In The Genital Herpes Market

35. Genital Herpes Market High Potential Countries, Segments and Strategies

• 35.1 Genital Herpes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genital Herpes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genital Herpes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer